Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

This is just insane to think that shareholders should be ok with this because getting distribution and starting sales of their fda cleared product is what we’ve been waiting for and now it’s here and we’re headed right back to where we were. So now we’re waiting to see what sales it generates? But what’s the share price gonna be if they’re good? We all have our own assumptions of what it could get too but again it’s a waiting game. idk what to think anymore I’m really so confused as to what management expects from their shareholders that it’s just fine